Neogen® To Participate in 2024 Wells Fargo Healthcare Conference

8/29/24 8:45:00 AM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Get the next $NEOG alert in real time by email

LANSING, Mich., Aug. 29, 2024 /PRNewswire/ -- Neogen^® Corporation (NASDAQ:NEOG) announced today that the Company will participate in the 2024 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 5.

David Naemura, Neogen's Chief Financial Officer, will present at 3:00 PM Eastern Time.

To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Media Contact

Bill Waelke, Vice President, IR & Treasury

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-to-participate-in-2024-wells-fargo-healthcare-conference-302233467.html

SOURCE Neogen Corporation

Get the next $NEOG alert in real time by email

Date	Price Target	Rating	Analyst
6/16/2023	$22.00	Overweight	Wells Fargo
11/22/2022		Mkt Perform → Outperform	William Blair
7/12/2022	$25.00	Neutral	Piper Sandler

Neogen® To Participate in 2024 Wells Fargo Healthcare Conference

Chat with this insight

Recent Analyst Ratings for $NEOG

$NEOG Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Neogen Corporation (Amendment)

SEC Form SC 13G/A filed by Neogen Corporation (Amendment)

SEC Form SC 13G/A filed by Neogen Corporation (Amendment)

$NEOG Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Bernard Thierry was granted 5,620 units of Restricted Stock Units (SEC Form 4)

SEC Form 3 filed by new insider Bernard Thierry

Director Woteki Catherine E exercised 1,776 shares at a strike of $13.81, increasing direct ownership by 31% to 7,474 units (SEC Form 4)

$NEOG Leadership Updates

Live Leadership Updates

Neogen Announces the Appointment of New Board Member

Neogen Announces the Appointment of Two New Board Members

$NEOG Market Insights

Live Market Insights

Inflation Slows Small Cap Rally, But SMCP ETF Offers Strategic Entry Point

Neogen Launches Petrifilm Automated Feeder to Enhance Efficiency for High-Volume Food Safety Testing Laboratories, Building on 40 Years of Innovation in Quality Indicator Testing

Neogen's Molecular Detection System Named Primary Method For Salmonella And Listeria Testing In Meat, Poultry, And Egg Products By USDA FSIS

$NEOG Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

CEO Adent John Edward bought $200,100 worth of shares (14,500 units at $13.80), increasing direct ownership by 7% to 216,477 units (SEC Form 4)

Director Tobin James P bought $50,571 worth of shares (3,000 units at $16.86), increasing direct ownership by 15% to 23,392 units (SEC Form 4)

Jones Douglas Edward bought $123,590 worth of shares (10,000 units at $12.36), increasing direct ownership by 28% to 46,131 units (SEC Form 4)

$NEOG SEC Filings

Neogen Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

SEC Form 10-Q filed by Neogen Corporation

Neogen Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

$NEOG Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Wells Fargo initiated coverage on Neogen with a new price target

Neogen upgraded by William Blair

Piper Sandler initiated coverage on Neogen with a new price target

$NEOG Press Releases

Fastest customizable press release news feed in the world

$NEOG Financials

Live finance-specific insights

Neogen® To Participate in 2024 UBS Global Healthcare Conference

Neogen Announces First-Quarter 2025 Results

Neogen Announces the Appointment of New Board Member

Neogen Announces First-Quarter 2025 Results

Neogen® Announces First-Quarter Earnings Release Date

Neogen Announces Fourth-Quarter 2024 Results

Recent Analyst Ratings for
$NEOG

$NEOG
Large Ownership Changes

$NEOG
Insider Trading

$NEOG
Leadership Updates

$NEOG
Market Insights

$NEOG
Insider Purchases

$NEOG
SEC Filings

$NEOG
Analyst Ratings

$NEOG
Press Releases

$NEOG
Financials